PlainRecalls
FDA Drug Moderate Class II Terminated

Telmisartan and Hyrdochlorothiazide Tablets, USP 80mg/12.5 mg, 30-coun bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Imachal Pradesh, India NDC 33342-129-07

Reported: March 20, 2019 Initiated: February 25, 2019 #D-1004-2019

Product Description

Telmisartan and Hyrdochlorothiazide Tablets, USP 80mg/12.5 mg, 30-coun bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Imachal Pradesh, India NDC 33342-129-07

Reason for Recall

Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.

Details

Recalling Firm
Macleods Pharma Usa Inc
Units Affected
140,589 bottles
Distribution
Nationwide within the United States
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Telmisartan and Hyrdochlorothiazide Tablets, USP 80mg/12.5 mg, 30-coun bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Imachal Pradesh, India NDC 33342-129-07. Recalled by Macleods Pharma Usa Inc. Units affected: 140,589 bottles.
Why was this product recalled?
Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 20, 2019. Severity: Moderate. Recall number: D-1004-2019.